What is the share price of Veerhealth Care Ltd (VEERHEALTH) today?
The share price of VEERHEALTH as on 14th November 2025 is ₹17.77. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Veerhealth Care Ltd (VEERHEALTH) share?
The past returns of Veerhealth Care Ltd (VEERHEALTH) share are- Past 1 week: -1.55%
- Past 1 month: -0.72%
- Past 3 months: -18.66%
- Past 6 months: 48.08%
- Past 1 year: -2.74%
- Past 3 years: 98.21%
- Past 5 years: 360.18%
What are the peers or stocks similar to Veerhealth Care Ltd (VEERHEALTH)?
The peers or stocks similar to Veerhealth Care Ltd (VEERHEALTH) include:What is the market cap of Veerhealth Care Ltd (VEERHEALTH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Veerhealth Care Ltd (VEERHEALTH) is ₹35.56 Cr as of 14th November 2025.What is the 52 week high and low of Veerhealth Care Ltd (VEERHEALTH) share?
The 52-week high of Veerhealth Care Ltd (VEERHEALTH) is ₹23.77 and the 52-week low is ₹9.29.What is the PE and PB ratio of Veerhealth Care Ltd (VEERHEALTH) stock?
The P/E (price-to-earnings) ratio of Veerhealth Care Ltd (VEERHEALTH) is 91.17. The P/B (price-to-book) ratio is 1.60.Which sector does Veerhealth Care Ltd (VEERHEALTH) belong to?
Veerhealth Care Ltd (VEERHEALTH) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Veerhealth Care Ltd (VEERHEALTH) shares?
You can directly buy Veerhealth Care Ltd (VEERHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Veerhealth Care Ltd
VEERHEALTH Share Price
17.770.17% (+0.03)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
VEERHEALTH Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
VEERHEALTH Performance & Key Metrics
VEERHEALTH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 74.08 | 1.60 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.95 | 5.83 | 0.59% |
VEERHEALTH Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
VEERHEALTH Company Profile
Veerhealth Care is engaged in manufacturing and marketing research-based Ayurvedic medicines. The Company's product categories include Tablets, Syrups, Ointments, Powder, Oil and Toothpaste.
SUNPHARMA
PE Ratio
38.14
38.14
1Y Return
2.34%
2.34%
Buy Reco %
91.43
91.43
TORNTPHARM
PE Ratio
67.75
67.75
1Y Return
22.77%
22.77%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.38
23.38
1Y Return
1.34%
1.34%
Buy Reco %
67.74
67.74
DRREDDY
PE Ratio
18.18
18.18
1Y Return
0.81%
0.81%
Buy Reco %
41.94
41.94
ZYDUSLIFE
PE Ratio
20.99
20.99
1Y Return
2.03%
2.03%
Buy Reco %
50.00
50.00
VEERHEALTH Sentiment Analysis
VEERHEALTH Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
VEERHEALTH Stock Summary · June 2024
VeerHealth Care Limited demonstrated robust financial performance in Q4 FY '24, with total income reaching INR 1,461.29 lakhs and a notable EBITDA margin of 13.70%. The company is strategically expanding its global footprint, particularly in the U.S. market, where it anticipates generating INR 25 to 30 crores annually from exports, bolstered by recent FDA registrations. While aiming for a turnover of INR 100 crores by March 2027, it plans to enhance its product offerings and e-commerce presence, despite facing challenges such as declining promoter shareholding. A strong commitment to quality and compliance, alongside operational upgrades, positions the company favorably for future growth and market confidence.
VEERHEALTH Stock Growth Drivers
VEERHEALTH Stock Growth Drivers
7Regulatory Milestones and Market Entry
VeerHealth Care Limited has achieved significant regulatory milestones, including the allocation of a US FDA
Strong Financial Performance
In FY '24, VeerHealth Care reported total income of INR 1,461.29 lakhs and an EBITDA
VEERHEALTH Stock Challenges
VEERHEALTH Stock Challenges
3Decline in Promoter Shareholding
The company's promoter shareholding has decreased significantly from 44.36% in December 2022 to 30% currently.
Reduction in Contract Manufacturing Revenue
The company anticipates a decrease in revenue from contract manufacturing, which currently accounts for 55%
VEERHEALTH Forecast
VEERHEALTH Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
VEERHEALTH
VEERHEALTH
Income
Balance Sheet
Cash Flow
Annual Normal View
VEERHEALTH Income Statement
VEERHEALTH Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.64 | 5.89 | 6.27 | 12.21 | 11.78 | 11.30 | 14.51 | 14.61 | 17.89 | 19.42 | ||||||||||
Raw Materials | 1.58 | 3.08 | 3.84 | 8.65 | 8.38 | 7.99 | 9.71 | 7.92 | 12.45 | 17.43 | ||||||||||
| Power & Fuel Cost | 0.08 | 0.11 | 0.10 | 0.22 | 0.25 | 0.20 | 0.20 | 0.24 | 0.37 | |||||||||||
| Employee Cost | 0.58 | 0.57 | 0.47 | 0.80 | 0.83 | 0.88 | 0.90 | 1.31 | 1.58 | |||||||||||
| Selling & Administrative Expenses | 0.26 | 0.46 | 0.49 | 0.62 | 0.48 | 0.78 | 1.63 | 1.37 | 1.89 | |||||||||||
| Operating & Other expenses | -0.22 | 1.07 | 0.64 | 0.76 | 0.58 | 0.59 | 0.33 | 1.77 | -0.08 | |||||||||||
EBITDA | 0.36 | 0.60 | 0.73 | 1.16 | 1.26 | 0.86 | 1.74 | 2.00 | 1.68 | 1.99 | ||||||||||
| Depreciation/Amortization | 0.23 | 0.27 | 0.32 | 0.32 | 0.47 | 0.52 | 0.62 | 0.71 | 0.91 | 1.10 | ||||||||||
| PBIT | 0.13 | 0.33 | 0.41 | 0.84 | 0.79 | 0.34 | 1.12 | 1.29 | 0.77 | 0.89 | ||||||||||
| Interest & Other Items | 0.10 | 0.07 | 0.03 | 0.19 | 0.22 | 0.09 | 0.00 | 0.01 | 0.26 | 0.35 | ||||||||||
| PBT | 0.03 | 0.26 | 0.38 | 0.65 | 0.57 | 0.25 | 1.12 | 1.28 | 0.51 | 0.54 | ||||||||||
| Taxes & Other Items | 0.01 | 0.11 | 0.22 | 0.33 | 0.20 | 0.31 | -0.46 | 0.88 | 0.12 | 0.06 | ||||||||||
| Net Income | 0.02 | 0.15 | 0.16 | 0.32 | 0.37 | -0.06 | 1.58 | 0.40 | 0.39 | 0.48 | ||||||||||
| EPS | 0.01 | 0.05 | 0.06 | 0.15 | 0.18 | -0.03 | 0.93 | 0.20 | 0.20 | 0.24 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
VEERHEALTH Company Updates
VEERHEALTH Stock Peers
VEERHEALTH Past Performance & Peer Comparison
VEERHEALTH Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Veerhealth Care Ltd | 91.17 | 1.60 | — |
| Sun Pharmaceutical Industries Ltd | 38.14 | 5.75 | 0.92% |
| Torrent Pharmaceuticals Ltd | 67.75 | 17.06 | 0.84% |
| Cipla Ltd | 23.38 | 3.94 | 1.05% |
VEERHEALTH Stock Price Comparison
Compare VEERHEALTH with any stock or ETFCompare VEERHEALTH with any stock or ETF
VEERHEALTH
VEERHEALTH Holdings
VEERHEALTH Shareholdings
VEERHEALTH Promoter Holdings Trend
VEERHEALTH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
VEERHEALTH Institutional Holdings Trend
VEERHEALTH Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 1.37%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
VEERHEALTH Shareholding Pattern
VEERHEALTH Shareholding Pattern
VEERHEALTH Shareholding History
VEERHEALTH Shareholding History
Foreign Institutions
smallcases containing VEERHEALTH stock
smallcases containing VEERHEALTH stock
Looks like this stock is not in any smallcase yet.
VEERHEALTH Events
VEERHEALTH Events
VEERHEALTH Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
VEERHEALTH has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
VEERHEALTH Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
VEERHEALTH has not given any dividends in last 5 years
VEERHEALTH Dividends
VEERHEALTH Dividends
Hmm, looks like data is unavailable here. Please come back after some timeVEERHEALTH Stock News & Opinions
VEERHEALTH Stock News & Opinions
Articles & Videos
Earnings
Veerhealth Care standalone net profit declines 16.67% in the September 2025 quarter
Net profit of Veerhealth Care declined 16.67% to Rs 0.25 crore in the quarter ended September 2025 as against Rs 0.30 crore during the previous quarter ended September 2024. Sales declined 22.72% to Rs 3.98 crore in the quarter ended September 2025 as against Rs 5.15 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales3.985.15 -23 OPM %13.079.32 - PBDT0.650.62 5 PBT0.340.42 -19 NP0.250.30 -17 Powered by Capital Market - Live
1 day agoCapital Market - Live
Corporate
Veerhealth Care to hold board meeting
Veerhealth Care will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Veerhealth Care receives fresh orders from its US customer
Veerhealth Care announced that following the successful completion of the USFDA audit and receiving approval on 16 May 2025, the company has successfully shipped 8 FCL shipments and fulfilled the received order. The company said, Despite ongoing tariff uncertainties, we have now received a fresh order from our US customer - a strong indication of their continued trust in our quality and reliability.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Veerhealth Care schedules AGM
Veerhealth Care announced that the 33th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Veerhealth Care standalone net profit rises 100.00% in the June 2025 quarter
Net profit of Veerhealth Care rose 100.00% to Rs 0.24 crore in the quarter ended June 2025 as against Rs 0.12 crore during the previous quarter ended June 2024. Sales rose 117.96% to Rs 4.49 crore in the quarter ended June 2025 as against Rs 2.06 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales4.492.06 118 OPM %-0.67-0.97 - PBDT0.520.34 53 PBT0.240.15 60 NP0.240.12 100 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Veerhealth Care schedules board meeting
Veerhealth Care will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Veerhealth Care reports standalone net loss of Rs 0.10 crore in the March 2025 quarter
Net Loss of Veerhealth Care reported to Rs 0.10 crore in the quarter ended March 2025 as against net loss of Rs 0.55 crore during the previous quarter ended March 2024. Sales rose 66.77% to Rs 5.62 crore in the quarter ended March 2025 as against Rs 3.37 crore during the previous quarter ended March 2024. For the full year,net profit declined 4.88% to Rs 0.39 crore in the year ended March 2025 as against Rs 0.41 crore during the previous year ended March 2024. Sales rose 26.10% to Rs 16.67 crore in the year ended March 2025 as against Rs 13.22 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales5.623.37 67 16.6713.22 26 OPM %-2.855.04 -2.764.69 - PBDT0.130.34 -62 1.422.00 -29 PBT-0.130.16 PL 0.511.29 -60 NP-0.10-0.55 82 0.390.41 -5 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Veerhealth Care to discuss results
Veerhealth Care will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Veerhealth Care standalone net profit declines 63.16% in the December 2024 quarter
Net profit of Veerhealth Care declined 63.16% to Rs 0.07 crore in the quarter ended December 2024 as against Rs 0.19 crore during the previous quarter ended December 2023. Sales rose 33.80% to Rs 3.84 crore in the quarter ended December 2024 as against Rs 2.87 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales3.842.87 34 OPM %3.915.92 - PBDT0.320.41 -22 PBT0.070.23 -70 NP0.070.19 -63 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Veerhealth Care to conduct board meeting
Veerhealth Care will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 7.94%, vs industry avg of 10.03%
Over the last 5 years, market share stayed at 0%
Over the last 5 years, net income has grown at a yearly rate of 4.04%, vs industry avg of 20.02%